Team:Calgary/Project

From 2014.igem.org

(Difference between revisions)
Line 1: Line 1:
{{Team:Calgary/Main}}
{{Team:Calgary/Main}}
<html>
<html>
 +
 +
 +
<img src="https://static.igem.org/mediawiki/2014/6/64/Projectmap.png" "width=100" class="Center">
<p><section class="Content Text Color-Normal">
<p><section class="Content Text Color-Normal">
Line 8: Line 11:
<p>Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering <a href="https://2014.igem.org/Team:Calgary/Sandbox/Notebook/References"#Journals>(Mabey, Peeling, Ustianowski, & Perkins, 2004)</a>. To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.</p>
<p>Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering <a href="https://2014.igem.org/Team:Calgary/Sandbox/Notebook/References"#Journals>(Mabey, Peeling, Ustianowski, & Perkins, 2004)</a>. To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.</p>
-
<img src="https://static.igem.org/mediawiki/2014/6/64/Projectmap.png" "width=100" class="Center">
 
</section>
</section>
</html>
</html>

Revision as of 21:54, 17 October 2014

Our Project

Infectious diseases including dengue fever, typhoid fever, and meningitis are symptomatically similar to malaria, and thus are often misdiagnosed in resource-poor developing countries lacking suitable medical diagnostic facilities. Failure to properly identify such diseases is concerning because it prevents medical professionals from administering appropriate treatments in a timely manner, resulting in economic costs and human suffering (Mabey, Peeling, Ustianowski, & Perkins, 2004). To address this issue, the iGEM Calgary 2014 team is developing a novel, genome-based, rapid point-of-care synthetic biological device to simultaneously diagnose multiple infectious diseases. We are engineering Bacillus subtilis to generate a chromophoric reporter protein in response to pathogenic genetic markers indicative of these diseases. These synthetic organisms will lie dormant as robust bacterial spores in a microfluidic device, enabling users to input blood samples and differentiate diseases based on colour of the output reporter proteins. Additionally, our system is a platform technology which can be adapted to detect a myriad of infectious agents by modifying the disease markers to which the system is targeted.